Precision Telemed review

Take a quarter dose here and it may genuinely cost you less — Precision Telemed sells a lowest-dose-only tier beneath each flat plan, prices it below the flat rate, and prints the exact milligram it is limited to on the tile. That is the answer this site exists to look for, and almost nothing else here has one. It also bounds its flat plans with a published milligram range rather than saying "all doses", names its compounding pharmacy in prose and states its 503A status. Three things will cost you. The lowest-dose tile is worded around maintaining your current weight, and nothing says whether a new patient can start there, so ask before you assume. The two product pages disagree with each other about first-month pricing, one promising no games and the other running an intro rate. And a scarcity counter shows the same number of remaining spots on both pages at once.

Vs median

$20/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Prices the low dose on its own

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

Precision Telemed dispenses through a 503A facility. No bloodwork is required before you start. A clinician review is included in the price.

Precision Telemed sells compounded semaglutide and compounded tirzepatide on flat monthly rates and publishes the milligram range each rate covers. Beneath each flat tier it sells a cheaper Maintenance Program tier badged as a microdose, limited to the lowest strength, with that strength printed on the tile. It names its compounding pharmacy in prose on the product page — Rush Pharmacy — states its 503A status, and says it ships to all 50 states. Its two product pages contradict each other on first-month pricing.

THE MAIN TIERS ARE FLAT ACROSS THEIR WHOLE RANGE, so a patient holding 0.25 mg on the standard semaglutide plan pays what one at 2.5 mg pays. The lowest-dose tier is the way out, and it is a separate product with a stated ceiling

• IT IS NOT STATED WHETHER THE MICRODOSE TIERS ARE OPEN TO NEW PATIENTS. The tile is worded "Maintain your current weight", which reads as a tier for patients who have already reached goal
• THE TWO PRODUCT PAGES CONTRADICT EACH OTHER ON FIRST-MONTH PRICING. The semaglutide page promises "No first-month pricing games"; the tirzepatide page runs "$199 first month · $249/mo after" — same company, same site
• A scarcity counter runs in the sticky footer of both pages — "Only 7 spots left this week" and "Only 7 consultations left this week" — showing the identical number on both
• A press strip lists Business Insider, Yahoo Finance, AP News, Digital Journal, Science Times and Digital Fitness World, a set consistent with press-release syndication rather than earned coverage
• The LegitScript badge links to a checker query rather than publishing a numeric seal ID
• No week count is published behind the monthly figure
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Precision Telemed is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan